AMKIRI

Visual Fragrance Technology

Health Tech & Life Sciences
Non Active, Jul 2023 ceased to operate

Company Overview

Snapshot

Founded in September 2014 by Shoval Shavit Shapiro and Aliza Shavit, AMKIRI operates with 1–10 employees. The company has secured $3 million in total capital across three funding rounds from six investors. In October 2021, AMKIRI announced a $3 million investment.

Business overview

AMKIRI has developed a proprietary Visual Fragrance technology that applies long-lasting scented ink to the skin using specialized applicators. This innovation allows users to create fragrant body art. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Cosmetic Materials, and serves the Beauty & Cosmetics segment of the Consumer Goods market across Europe, Asia, and the United States.

Strategic signal

In October 2021, AMKIRI announced a $3 million investment, signaling continued investor confidence in its unique Visual Fragrance technology. This funding round, led by Welltech Ventures, underscores the market's interest in innovative cosmetic materials and direct-to-consumer beauty solutions, positioning AMKIRI for further development and market penetration in the beauty and wellness industries.

Company Intelligence Q&A

What is AMKIRI's core technology?
AMKIRI has developed Visual Fragrance technology, which enables the application of long-lasting scented ink to the skin via specialized applicators, allowing users to create body art infused with fragrance.
When was AMKIRI founded and by whom?
AMKIRI was founded in September 2014 by Shoval Shavit Shapiro and Aliza Shavit.
What was a significant funding event for AMKIRI?
In October 2021, AMKIRI announced an investment of $3 million, with Welltech Ventures participating as a lead investor.
Which competition did AMKIRI win in October 2018?
In October 2018, AMKIRI won the Globes EY ThePITCH startup competition.
What is the current status of AMKIRI?
AMKIRI is currently Non Active, having ceased to operate in July 2023.